Trademark: 87143093
Status Date
Monday, March 13, 2017
Filing Date
Thursday, August 18, 2016
Published for Opposition
Tuesday, March 7, 2017
Abandoned Date
Monday, March 13, 2017
5 Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Mar 13, 2017
Abandonment Notice Mailed - After Publication
Mar 13, 2017
Abandonment - After Publication
Mar 8, 2017
Teas Express Abandonment Received
Mar 7, 2017
Extension Of Time To Oppose Received
Mar 7, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2017
Published For Opposition
Feb 15, 2017
Notification Of Notice Of Publication E-Mailed
Feb 2, 2017
Law Office Publication Review Completed
Jan 18, 2017
Approved For Pub - Principal Register
Jan 6, 2017
Teas/Email Correspondence Entered
Jan 6, 2017
Correspondence Received In Law Office
Dec 15, 2016
Assigned To Lie
Dec 1, 2016
Teas Response To Suspension Inquiry Received
Nov 21, 2016
Notification Of Letter Of Suspension E-Mailed
Nov 21, 2016
Letter Of Suspension E-Mailed
Nov 21, 2016
Suspension Letter Written
Nov 16, 2016
Assigned To Examiner
Aug 23, 2016
New Application Office Supplied Data Entered In Tram
Aug 22, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
